Pharmacological and computational evaluation of Sapodilla and its constituents for therapeutic potential in hyperactive gastrointestinal disorders

被引:0
|
作者
Riaz, Muhammad Bilal [1 ]
Khan, Arif-ullah [1 ]
Qazi, Neelam Gul [1 ]
机构
[1] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Islamabad, Pakistan
关键词
Anti-diarrheal; Anti-secretory; Anti-spasmodic; Anti-ulcer; Manilkara zapota; Molecular docking; CASTOR-OIL; DERIVATIVES; AGONISTS; RAT;
D O I
10.22038/IJBMS.2019.35595.8488
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s): This study was designed to investigate various gastrointestinal effects of Manilkara zapota (Sapodilla), exploring its anti-diarrheal, anti-secretary, anti-spasmodic, anti-ulcer and antimotility potential. Materials and Methods: Antidiarrheal and anti-secretary activities were investigated using castor oil induced diarrhea and castor oil induced fluid accumulation. Isolated rabbit jejunum tissues (antispasmodic) were employed for in vitro experiments. Antiulcer, antimotility and molecular docking were performed using ethanol-HCl induced ulcer assay, charcoal meal transit time and Auto Doc Vina. Results: Mz.Cr exhibited protection against castor oil-induced diarrhea (P<0.05 vs. saline group) and dose-dependently inhibited intestinal fluid secretions (P<0.001 vs. castor oil group). Mz.Cr caused relaxation of spontaneous and K+ (80 Mm)-induced contractions with EC50 values of 0.11mg/ml (0.08-0.1, n=4) and 0.16 mg/ml (0.09-0.2, n=4) respectively (*P<0.05**P<0.01 ***P<0.001). It showed protective effect against gastric ulcers induced by ethanol-HCl (P<0.001 vs. saline group). Mz.Cr reduced distance travelled by charcoal meal (P<0.001 vs. saline group). Plant constituents: caffeoylquinic acid and methyl 4-O-galloylchlorogenate showed high binding affinities (E-value-6.5 Kcal/mol) against histaminergic H-2 receptors, H+/K+ ATPase pump and voltage gated L-type calcium channels, while possesses moderate affinities (E-value >= 8 Kcal/mol) against histaminergic H-1, muscarinic M-1, M-3 and mu-opioid, whereas lower affinities (E-value >= 9.5 Kcal/mol) vs. calmodulin, adrenergic alpha(1), phosphodiesterase enzyme and dopaminergic D-2 receptors. Lupeol-3-acetate and beta-amyrin-3-(3'-dimethyl) butyrate observed weak affinities. Conclusion: In present study, M. zapota is reported to exhibits anti-diarrheal, anti-secretory, antispasmodic, anti-motility, anti-ulcer effects and computational binding affinities against gastrointestinal targets.
引用
收藏
页码:224 / 235
页数:12
相关论文
共 50 条
  • [41] Exploring the Therapeutic Potential of Royal Jelly in Metabolic Disorders and Gastrointestinal Diseases
    El-Seedi, Hesham R.
    Salama, Suzy
    El-Wahed, Aida A. Abd
    Guo, Zhiming
    Di Minno, Alessandro
    Daglia, Maria
    Li, Chuan
    Guan, Xiao
    Buccato, Daniele Giuseppe
    Khalifa, Shaden A. M.
    Wang, Kai
    NUTRIENTS, 2024, 16 (03)
  • [42] PERINDOPRIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR DISORDERS
    TODD, PA
    FITTON, A
    DRUGS, 1991, 42 (01) : 90 - 114
  • [43] Carvedilol - A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders
    Dunn, CJ
    Lea, AP
    Wagstaff, AJ
    DRUGS, 1997, 54 (01) : 161 - 185
  • [44] RAMIPRIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN CARDIOVASCULAR DISORDERS
    TODD, PA
    BENFIELD, P
    DRUGS, 1990, 39 (01) : 110 - 135
  • [45] CarvedilolA Reappraisal of its Pharmacological Properties and Therapeutic Use in Cardiovascular Disorders
    Christopher J. Dunn
    Andrew P. Lea
    Antona J. Wagstaff
    Drugs, 1997, 54 : 161 - 185
  • [46] QUINAPRIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC EFFICACY IN CARDIOVASCULAR DISORDERS
    WADWORTH, AN
    BROGDEN, RN
    DRUGS, 1991, 41 (03) : 378 - 399
  • [47] FLUNARIZINE - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN NEUROLOGICAL DISORDERS
    TODD, PA
    BENFIELD, P
    DRUGS, 1989, 38 (04) : 481 - 499
  • [48] Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review
    Risha Ganguly
    Ashutosh Gupta
    Abhay K Pandey
    World Journal of Gastroenterology, 2022, (26) : 3047 - 3062
  • [49] ATENOLOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR DISORDERS
    WADWORTH, AN
    MURDOCH, D
    BROGDEN, RN
    DRUGS, 1991, 42 (03) : 468 - 510
  • [50] IBUPROFEN - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN RHEUMATIC DISORDERS
    DAVIES, EF
    AVERY, GS
    DRUGS, 1971, 2 (05) : 416 - &